Lipid Sciences, Inc.'s HDL Selective Delipidation Featured As A Radical Approach To Treating Heart Disease

PLEASANTON, CA -- (MARKET WIRE) -- November 15, 2006 -- Lipid Sciences, Inc. (NASDAQ: LIPD). In the story “Cholesterol Clean-Out,” Lipid Sciences’ HDL Selective Delipidation technology was featured as a radical approach to treating heart disease by making good cholesterol even better. The story was first broadcast on Monday, November 13, 2006 on the Washington, D.C., NBC affiliate, WRC-TV, News 4.

MORE ON THIS TOPIC